Urinary Tract Infection (UTI) Drugs/Treatment Market is Expected to Grow at a CAGR of 28.4% By 2022
Urinary Tract Infection (UTI) Drugs are used for the treatment of urinary tract infection caused by bacterial or fungal infections. World Health Organization (WHO) estimates that approximately 50 % of women have Urinary Tract Infection at some point in their lives resulting in more than $1 million hospitalizations per year. WHO estimates the cost of Urinary Tract Infection (UTI) infections to be annually greater than USD 1 Billion. It has further been stated that chances of boys being diagnosed with UTI is 1% while chances of girls being diagnosed with Urinary Tract Infection (UTI) is 3 to 8%.
The Middle East and Africa Urinary Tract Infection (UTI) drugs market is growing due to factors such as catheter associated Urinary Tract Infection, hospital borne infections (nosocomial infections), childbirth, old age, obesity, growing health awareness especially about women health etc. On the other hand, market constraints include excellent efficacy of present antibiotics specially quinolones, growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases etc.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/2540
However, the rise of drug resistance has created the need for novel acting antibiotic. The future of Urinary Tract Infection (UTI) treatment seems to be development of biologics with greater market development especially with respect to poorly growing African market. The loss of patents, weakening developed pipelines and poor expenditure on health in African region had further constrained the market growth.
The Middle East and Africa Urinary Tract Infection (UTI) drugs market has been segmented into drug class which includes
- Quinolones,
- Aminoglycosides,
- β-lactam,
- Azoles
- Others
Among all these drug classes quinolones have the largest market value due to their broad variety and excellent efficacy. The share of aminoglycosides has been reduced by a small margin as this drug is resistance. Thus, the current trend in Urinary Tract Infection (UTI) treatment is combined drug regimen. The market threat includes a form of substandard, counterfeit and spurious drugs have emerged. However, it has to be noted that a huge unmet need exists for these drugs in the Middle East and African region.
Brows Full Research Report with TOC on “ Urinary Tract Infection Drugs Market” at: https://www.marketresearchfuture.com/reports/mea-uti-drugs-market-2540
Urinary Tract Infection Treatment Market Key Players:
Major participants of this market are:
- Bayer AG
- Novartis AG
- Pfizer Inc.
- Hoffmann-La Roche Ltd
- AstraZeneca
- Cipla Inc.
- Reddy’s Laboratories Ltd
- others
Middle East and Africa Urinary Tract Infection (UTI) Drugs market:
The Middle East and Africa Urinary Tract Infection drugs market has been evaluated to be growing market and is expected that the market will grow moderately in the future. The Middle East and Africa UTI drugs market is expected to grow with the CAGR of 4.35% during the forecast period. The growth will primary be led by unmet medical needs and rising incomes of the population.
Urinary Tract Infection Treatment Market Regional Analysis:
Depending on geographic region, Urinary Tract Infection drugs market is segmented into following countries:
- UAE
- Egypt
- Saudi Arabia
- Kuwait
- Qatar
- Oman
UAE is the largest market followed by Egypt. However, the future market will be led by poorly developed parts of Africa due to large unmet needs.
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
To Be Continued…………..
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
